Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells.

Int J Mol Sci · 2025 · PMC11942989 · PMID 40141362

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Pathway analysis in samples collected and processed for next-generation RNA-seq showed highly significant downregulation of cell-cycle-related genes [ 226 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.